As of 2025-05-13, the Intrinsic Value of Calithera Biosciences Inc (CALA) is -148,664.00 USD. This CALA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.37 USD, the upside of Calithera Biosciences Inc is -40,718,806.00%.
Based on its market price of 0.37 USD and our intrinsic valuation, Calithera Biosciences Inc (CALA) is overvalued by 40,718,806.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -148,664.00 - -148,664.00 | -148,664.00 | -40,718,806.00% |
| P/E | (665,419.71) - (1,135,197.71) | (781,972.23) | -214180387.5% |
| DDM - Stable | (258,116.86) - (1,258,831.16) | (758,470.89) | -207743426.5% |
| DDM - Multi | (224,445.19) - (897,448.88) | (364,520.49) | -99841373.1% |
| Market Cap (mil) | 0.00 |
| Beta | -12.83 |
| Outstanding shares (mil) | 0.00 |
| Enterprise Value (mil) | -25.50 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.09% |
| Cost of Debt | 5.00% |
| WACC | 6.38% |